Search - tctmd.com

Displaying 301 - 320 of 979

Sort: Relevancy | Date

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Todd Neale

March 22, 2023

Presentation THT 2023

No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Six-Month Outcomes From Multi-Center Pilot Feasibility Studies

Presenter: James Udelson

March 22, 2023

Presentation THT 2023

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Presenter: Sheldon Litwin

March 21, 2023

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Todd Neale

March 21, 2023

Presentation THT 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Presenter: Marat Fudim

March 21, 2023

Presentation THT 2023

Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial

Presenter: Matteo Pagnesi

March 21, 2023

Presentation THT 2023

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

Presenter: Michael Zile

March 21, 2023

Presentation THT 2023

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

Presenter: Tyler Bonkowski

March 21, 2023

Presentation THT 2023

InterShunt: Cut, Capture and Leave Nothing Behind

Presenter: Robin Germany

March 20, 2023

Presentation THT 2023

V-Wave: Different Shape, Different Effect?

Presenter: JoAnn Lindenfeld

March 20, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

Alleviant: Leave Nothing Behind

Presenter: James Udelson

March 20, 2023

Presentation THT 2023

Implications of Left Atrial Hypertension at Rest and Exercise

Presenter: Sheldon Litwin

March 20, 2023

Presentation THT 2023

IASDs: What We Know and What We Don't Know

Presenter: Sanjiv Shah

March 20, 2023

$Electrocardiographic-based artificial intelligence model in prediction of 1-year mortality in heart failure with reduced ejection fraction$

Presentation THT 2023

Electrocardiographic-based artificial intelligence model in prediction of 1-year mortality in heart failure with reduced ejection fraction

Presenter: Hak Seung Lee

March 20, 2023

Presentation THT 2023

Right Heart Failure with Preserved Ejection Fraction: A New Clinical Phenotype with Clinical and Prognostic Relevance

Presenter: Athiththan Yogeswaran

March 20, 2023

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

Todd Neale

March 15, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Conference News ACC 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

Todd Neale

March 09, 2023

Advertisement

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Six-Month Outcomes From Multi-Center Pilot Feasibility Studies

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Left Ventricular Ejection Fraction and Intensive Up-Titration of Oral Treatment in Patients Recently Hospitalized for Heart Failure: Insights From the STRONG-HF Trial

Baroreflex Activation Therapy (BAT) in Patients With Heart Failure and a Reduced Ejection Fraction (BeAT-HF): Long-Term Outcomes

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

InterShunt: Cut, Capture and Leave Nothing Behind

V-Wave: Different Shape, Different Effect?

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Alleviant: Leave Nothing Behind

Implications of Left Atrial Hypertension at Rest and Exercise

IASDs: What We Know and What We Don't Know

Electrocardiographic-based artificial intelligence model in prediction of 1-year mortality in heart failure with reduced ejection fraction

Right Heart Failure with Preserved Ejection Fraction: A New Clinical Phenotype with Clinical and Prognostic Relevance

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content